Pathophysiology of Latent Autoimmune Diabetes

Latent Autoimmune Diabetes in Adults (LADA) is a type of diabetes that exhibits features of both Type 1 and Type 2 diabetes. It typically manifests in adults over the age of 30 and is characterized by a gradual onset of insulin deficiency due to autoimmune destruction of pancreatic beta cells. Unlike classic Type 1 diabetes, LADA progresses more slowly, often initially being misdiagnosed as Type 2 diabetes due to the presence of insulin resistance. The pathophysiology involves the activation of autoantibodies against pancreatic islet cells, leading to an inflammatory response and subsequent beta-cell dysfunction. This autoimmune attack results in a gradual decline in insulin production, ultimately necessitating insulin therapy. Understanding LADA is crucial for appropriate management, as early intervention can help delay complications associated with diabetes.

Committee Members
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - Wan Rosli Wan Ishak

Wan Rosli Wan Ishak

Universiti Sains Malaysia, Malaysia
Diabetes 2026 Speakers
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - David Navazio

David Navazio

Gentell, United States
Speaker at Diabetes  2026 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes  2026 - David Petch

David Petch

utR Biotech, Canada
Tags

Submit your abstract Today

YouTube
WhatsAppWhatsApp